Giuseppe Schepisi
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 19, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.
Journal: Prostate cancer and prostatic diseases
Published: October 16, 2025
Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?
Journal: The Journal of pathology
Published: September 03, 2025
Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives.
Journal: Discover oncology
Published: August 11, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience.
Journal: European urology oncology
Published: February 18, 2025
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Journal: Expert review of anticancer therapy
Published: December 24, 2024
Validation of a Combined Prognostic Score Using Plasma Tumor DNA and Clinical Features in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Taxanes.
Journal: OncoTargets and therapy
Published: December 10, 2024
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.
Journal: ESMO open
Published: September 11, 2024
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 26, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
Journal: European urology open science
Published: January 25, 2024
Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.
Journal: International journal of molecular sciences
Published: October 22, 2023
Last Updated: 09/26/2026